Skip to main content

Advertisement

Log in

Clofazimine-Loaded Mucoadhesive Nanoparticles Prepared by Flash Nanoprecipitation for Strategic Intestinal Delivery

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

This study was undertaken to develop novel mucoadhesive formulations of clofazimine (CFZ), a drug candidate for the treatment of cryptosporidiosis, with the aim of strategic delivery to the small intestine, the main site of the disease parasites.

Methods

CFZ-loaded nanoparticles (nCFZ) coated with non-biodegradable anionic polymer (nCFZ/A) and biodegradable anionic protein complex (nCFZ/dA) were prepared by Flash NanoPrecipitation (FNP) and evaluated for their physicochemical and biopharmaceutical properties.

Results

The mean diameters of nCFZ/A and nCFZ/dA were ca. 90 and 240 nm, respectively, and they showed narrow size distributions and negative ζ-potentials. Both formulations showed higher solubility of CFZ in aqueous solution than crystalline CFZ. Despite their improved dispersion behaviors, both formulations exhibited significantly lower diffusiveness than crystalline CFZ in a diffusion test using artificial mucus (AM). Quartz crystal microbalance analysis showed that both formulations clearly interacted with mucin, which appeared to be responsible for their reduced diffusiveness in AM. These results suggest the potent mucoadhesion of nCFZ/A and nCFZ/dA. After the oral administration of CFZ samples (10 mg-CFZ/kg) to rats, nCFZ/dA and nCFZ/A exhibited a prolongation in Tmax by 2 and >9 h, respectively, compared with crystalline CFZ. At 24 h after oral doses of nCFZ/A and nCFZ/dA with mucoadhesion, there were marked increases in the intestinal CFZ concentration (4–7 fold) compared with Lamprene®, a commercial CFZ product, indicating enhanced CFZ exposure in the small intestine.

Conclusion

The use of FNP may produce mucoadhesive CFZ formulations with improved intestinal exposure, possibly offering enhanced anti-cryptosporidium therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global enteric Multicenter study, GEMS): a prospective, case-control study. Lancet. 2013;382(9888):209–22.

    Article  Google Scholar 

  2. Manabe YC, Clark DP, Moore RD, Lumadue JA, Dahlman HR, Belitsos PC, Chaisson RE, Sears CL. Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin Infect Dis. 1998;27(3):536–42.

    Article  CAS  Google Scholar 

  3. Bouzid M, Hunter PR, Chalmers RM, Tyler KM. Cryptosporidium pathogenicity and virulence. Clin Microbiol Rev. 2013;26(1):115–34.

    Article  CAS  Google Scholar 

  4. Amadi B, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub A, Kelly P. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. 2002;360(9343):1375–80.

    Article  Google Scholar 

  5. Amadi B, Mwiya M, Sianongo S, Payne L, Watuka A, Katubulushi M, Kelly P. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect Dis. 2009;9:195.

    Article  Google Scholar 

  6. Manjunatha UH, Vinayak S, Zambriski JA, Chao AT, Sy T, Noble CG, Bonamy GMC, Kondreddi RR, Zou B, Gedeck P, Brooks CF, Herbert GT, Sateriale A, Tandel J, Noh S, Lakshminarayana SB, Lim SH, Goodman LB, Bodenreider C, et al. A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis. Nature. 2017;546(7658):376–80.

    Article  CAS  Google Scholar 

  7. Hewitt RG, Yiannoutsos CT, Higgs ES, Carey JT, Geiseler PJ, Soave R, Rosenberg R, Vazquez GJ, Wheat LJ, Fass RJ, Antoninievic Z, Walawander AL, Flanigan TP, Bender JF. Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS clinical trial group. Clin Infect Dis. 2000;31(4):1084–92.

    Article  CAS  Google Scholar 

  8. Love MS, Beasley FC, Jumani RS, Wright TM, Chatterjee AK, Huston CD, Schultz PG, McNamara CW. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis. PLoS Negl Trop Dis. 2017;11(2):e0005373.

    Article  Google Scholar 

  9. Baik J, Stringer KA, Mane G, Rosania GR. Multiscale distribution and bioaccumulation analysis of clofazimine reveals a massive immune system-mediated xenobiotic sequestration response. Antimicrob Agents Chemother. 2013;57(3):1218–30.

    Article  CAS  Google Scholar 

  10. Netsomboon K, Bernkop-Schnurch A. Mucoadhesive vs. mucopenetrating particulate drug delivery. Eur J Pharm Biopharm. 2016;98:76–89.

    Article  CAS  Google Scholar 

  11. Takeuchi H, Matsui Y, Yamamoto H, Kawashima Y. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release. 2003;86(2–3):235–42.

    Article  CAS  Google Scholar 

  12. Suwannateep N, Banlunara W, Wanichwecharungruang SP, Chiablaem K, Lirdprapamongkol K, Svasti J. Mucoadhesive curcumin nanospheres: biological activity, adhesion to stomach mucosa and release of curcumin into the circulation. J Control Release. 2011;151(2):176–82.

    Article  CAS  Google Scholar 

  13. Gao L, Liu G, Ma J, Wang X, Zhou L, Li X. Drug nanocrystals: in vivo performances. J Control Release. 2012;160(3):418–30.

    Article  CAS  Google Scholar 

  14. Zhang Y, Feng J, McManus SA, Lu HD, Ristroph KD, Cho EJ, Dobrijevic EL, Chan HK, Prud'homme RK. Design and solidification of fast-releasing Clofazimine nanoparticles for treatment of cryptosporidiosis. Mol Pharm. 2017;14(10):3480–8.

    Article  CAS  Google Scholar 

  15. Johnson BK, Prud'homme RK. Flash NanoPrecipitation of organic actives and block copolymers using a confined impinging jets mixer. Aust J Chem. 2003;56(10):1021–4.

    Article  CAS  Google Scholar 

  16. Liu Y, Cheng CY, Liu Y, Prud'homme RK, Fox RO. Mixing in a multi-inlet vortex mixer (MIVM) for flash nano-precipitation. Chem Eng Sci. 2008;63(11):2829–42.

    Article  CAS  Google Scholar 

  17. Markwalter CE, Pagels RF, Wilson BK, Ristroph KD, Prud'homme RK. Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles. J Vis Exp. 2019(143).

  18. Weissmueller NT, Lu HD, Hurley A, Prud'homme RK. Nanocarriers from GRAS Zein proteins to encapsulate hydrophobic actives. Biomacromolecules. 2016;17(11):3828–37.

    Article  CAS  Google Scholar 

  19. Craparo EF, Porsio B, Sardo C, Giammona G, Cavallaro G. Pegylated Polyaspartamide-Polylactide-based nanoparticles penetrating cystic fibrosis artificial mucus. Biomacromolecules. 2016;17(3):767–77.

    Article  CAS  Google Scholar 

  20. Sato H, Kaneko Y, Yamada K, Ristroph KD, Lu HD, Seto Y, Chan HK, Prud'homme RK, Onoue S. Polymeric Nanocarriers with mucus-diffusive and mucus-adhesive properties to control pharmacokinetic behavior of orally dosed cyclosporine a. J Pharm Sci. 2020;109(2):1079–85.

    Article  CAS  Google Scholar 

  21. Olmsted SS, Padgett JL, Yudin AI, Whaley KJ, Moench TR, Cone RA. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J. 2001;81(4):1930–7.

    Article  CAS  Google Scholar 

  22. Ponchel G, Montisci MJ, Dembri A, Durrer C, Duchene D. Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract. Eur J Pharm Biopharm. 1997;44(1):25–31.

    Article  CAS  Google Scholar 

  23. Leal J, Smyth HDC, Ghosh D. Physicochemical properties of mucus and their impact on transmucosal drug delivery. Int J Pharm. 2017;532(1):555–72.

    Article  CAS  Google Scholar 

  24. Lai SK, O'Hanlon DE, Harrold S, Man ST, Wang YY, Cone R, Hanes J. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci U S A. 2007;104(5):1482–7.

    Article  CAS  Google Scholar 

  25. Feng J, Zhang Y, McManus SA, Ristroph KD, Lu HD, Gong K, White CE, Prud’homme RK. Rapid recovery of clofazimine-loaded nanoparticles with long-term storage stability as anti-cryptosporidium therapy. ACS applied nano materials. 2018;1(5):2184–94.

    Article  CAS  Google Scholar 

  26. Jinno J, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M, Toguchi H, Liversidge GG, Higaki K, Kimura T. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release. 2006;111(1–2):56–64.

    Article  CAS  Google Scholar 

  27. Chayed S, Winnik FM. In vitro evaluation of the mucoadhesive properties of polysaccharide-based nanoparticulate oral drug delivery systems. Eur J Pharm Biopharm. 2007;65(3):363–70.

    Article  CAS  Google Scholar 

  28. Yawalkar SJ, Vischer W. Lamprene (Clofazimine) in Leprosy. Leprosy Rev. 1979;50(2):135–44.

    Article  CAS  Google Scholar 

  29. Horter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev. 2001;46(1–3):75–87.

    Article  CAS  Google Scholar 

Download references

Funding

This work was financially supported by JSPS KAKENHI [a Grant-in-Aid for Scientific Research (C) (No. 20 K07158: S. Onoue, No. 20 K07180: H. Sato)]. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. #DGE-1656466 awarded to KDR.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Robert K. Prud’homme or Satomi Onoue.

Ethics declarations

Conflict of Interest

The authors declare no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

ESM 1 (DOCX 265 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamada, K., Ristroph, K.D., Kaneko, Y. et al. Clofazimine-Loaded Mucoadhesive Nanoparticles Prepared by Flash Nanoprecipitation for Strategic Intestinal Delivery. Pharm Res 38, 2109–2118 (2021). https://doi.org/10.1007/s11095-021-03144-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-021-03144-3

Keywords

Navigation